Ascendis Pharma Investigational Site

Roma 00167

0 studies enrolling now · 2 studies all time

What they study most

2L+ Cervical Cancer, Advanced Solid Tumor, Endocrine System Diseases, Growth Hormone Deficiency, Pediatric, Hormones, Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoadjuvant Melanoma, Neoadjuvant Non-Small Cell Lung Cancer, Pituitary Diseases, Platinum-resistant Ovarian Cancer, Post Anti-PD-(L)1 Non-Small Cell Lung Cancer

Studies at this site

• A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) — Completed
• A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies — Running, not enrolling